Neurological Institute, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Neurology Department, Coimbra University Hospital Centre, 3004-561 Coimbra, Portugal.
Int J Mol Sci. 2022 Oct 30;23(21):13216. doi: 10.3390/ijms232113216.
Primary mitochondrial diseases are relatively common inborn errors of energy metabolism, with a combined prevalence of 1 in 4300. These disorders typically affect tissues with high energy requirements, including the brain. Epilepsy affects >1% of the worldwide population, making it one of the most common neurological illnesses; it may be the presenting feature of a mitochondrial disease, but is often part of a multisystem clinical presentation. The major genetic causes of mitochondrial epilepsy are mutations in mitochondrial DNA and in the nuclear-encoded gene POLG. Treatment of mitochondrial epilepsy may be challenging, often representing a poor prognostic feature. This narrative review will cover the most recent advances in the field of mitochondrial epilepsy, from pathophysiology and genetic etiologies to phenotype and treatment options.
原发性线粒体疾病是一种相对常见的能量代谢遗传性疾病,其总体患病率为 1/4300。这些疾病通常影响能量需求较高的组织,包括大脑。癫痫影响全球超过 1%的人口,是最常见的神经疾病之一;它可能是线粒体疾病的首发表现,但通常也是多系统临床表现的一部分。线粒体癫痫的主要遗传病因是线粒体 DNA 和核编码基因 POLG 的突变。线粒体癫痫的治疗可能具有挑战性,通常是预后不良的特征。本综述将涵盖线粒体癫痫领域的最新进展,包括病理生理学、遗传病因、表型和治疗选择。